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Background: This study was performed to understand the possible therapeutic activity of Terminalia paniculata
ethanolic extract (TPEE) on non alcoholic fatty liver in rats fed with high fat diet.
Methods: Thirty six SD rats were divided into 6 groups (n = 6): Normal control (NC), high fat diet (HFD), remaining
four groups were fed on HFD along with different doses of TPEE (100,150 and 200 mg/kg b.wt) or orlistat, for ten
weeks. Liver tissue was homogenized and analyzed for lipid profiles, activities of superoxide dismutase (SOD),
catalase (CAT) and malondialdehyde (MDA) content. Further, the expression levels of FAS and AMPK-1α were also
studied in addition to histopathology examination of liver tissue in all the groups.
Results: HFD significantly increased hepatic liver total cholesterol (TC), triglycerides (TG), free fatty acids (FFA) and
MDA but decreased the activities of SOD and CAT which were subsequently reversed by supplementation with
TPEE in a dose-dependent manner. In addition, TPEE administration significantly down regulated hepatic mRNA
expression of FAS but up regulated AMPK-1α compared to HFD alone fed group. Furthermore, western blot analysis
of FAS has clearly demonstrated decreased expression of FAS in HFD + TPEE (200 mg/kg b.wt) treated group when
compared to HFD group at protein level.
Conclusions: Our biochemical studies on hepatic lipid profiles and antioxidant enzyme activities supported by
histological and expression studies suggest a potential therapeutic role for TPEE in regulating obesity through FAS.
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HistopathologyBackground
Obesity is a well known risk factor for a variety of life
style disorders, such as type 2 diabetes, hyperlipidemia,
atherosclerosis, cardiovascular diseases and certain can-
cers [1,2]. It is characterized by accumulation of excess
fat in the body and dysregulation of lipid metabolism
[3]. The role of fatty acid synthase is implicated in the
regulation of fatty acid synthesis and net accumulation
of lipid in liver and adipose tissue [4]. Previous studies
showed that high fat diets result in non- alcoholic hep-
atic steatosis (NAHS). Nearly 70-90% of the non alco-
holic fatty liver problems were observed in obese and* Correspondence: balaji.meriga@gmail.com
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unless otherwise stated.diabetic patients. The NAHS is characterized by accu-
mulation of excessive triacylglycerol (TAG) within hepa-
tocytes and the condition can progress into more serious
liver diseases, such as liver fibrosis, cirrhosis, non alco-
holic steatohepatites [4-6]. A few pharmaceutical syn-
thetic drugs, fibrates and statins are available to treat
obesity. However due to adverse side effects they are not
preferred for long time usage [7]. Therefore, attempts
are being made to develop natural product-based safe
and effective drugs to treat obesity [8,9].
Terminalia paniculata Roth. (Combretaceae) is a trop-
ical tree with a large natural distribution in western and
southern parts of India. Traditionally, flower juice and
bark of T. paniculata have been used to treat cholera,
inflammation of parotid glands and menstrual disorders
[10], cough, bronchitis, cardiac debility, hepatitis andtral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 2 Effect of TPEE on liver lipid levels of control and
HFD-fed rats
Groups Total cholesterol Triglycerides Free fatty acids
NC 2.32 ± 0.25 78.83 ± 6.85 5.8 ± 1.15
HFD 4.60 ± 0.25# 171.8 ± 9.2# 12.6 ± 2.4#
ORL 2.38 ± 0.21* 90 ± 11.0* 4.42 ± 1.17*
TPEE100 4.10 ± 0.24 151 ± 10.7 10.5 ± 1.70
TPEE150 3.67 ± 0.27* 137.6 ± 6.2* 8.5 ± 1.67*
TPEE200 2.87 ± 0.15* 99 ± 10.8* 5.5 ± 2.12*
F Value 98.830 95.489 19.721
Significance 0.000 0.000 0.000
The data are expressed as the mean ± S.D (n = 6). Values are tested by ANOVA
with Duncan’s multiple range tests. #P < 0.05 significantly different from
normal control, *P < 0.05 significantly different from HFD control. NC: Normal
control group, HFD: high-fat diet group, ORL: Orlistat, TPEE: T. Paniculata
ethanolic extract (100, 150 and 200 mg/kg/day).
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Phytochemicals such as Ellagic acid, Dimethylellagic
acid, Pentamethyl flavellagic acid, Trimethyl flavellagic
acid and β-Sitosterol have been isolated from the
heartwood of T. paniculata. The bark was reported to
contain 14% tannins which have a pyrogallol nucleus
along with gallic acid [14]. The anti oxidant activity of
this plant was evaluated with DPPH (2, 2 Diphenyl-1-
picrylhydrazyl) by Shalu et al. [15]. Till now there are
only few reports about the therapeutic activity of Ter-
minalia paniculata and its phytochemicals, but there
are hardly any reports in understanding the anti-obesity
activity of this plant. Hence, our present work was aimed
to investigate the protective effect of TPEE in non alco-
holic fatty liver development and to understand the role of
genes such as FAS and AMPK-1α in HFD-fed obese rats.
Results
Measurement of body and organ weights
After the end of the experimental period, rats were
weighed and body weights noted. HFD-fed rats showed
substantial raise in body weight gain, compared to nor-
mal control group. However, HFD + TPEE (100, 150 and
200 mg/kg b.wt) administered rats showed significant
decrease in weight gain compared to HFD control group
(Table 1). Table 1 compares and explains body and organ
weights of different groups. The liver and kidney weights
of HFD-fed rats increased considerably which were sig-
nificantly (p < 0.05) and dose dependently reduced by
TPEE treatment. Whereas spleen and testis of TPEE
treated groups did not show any significant variation
compared to HFD control.
Hepatic lipid profiles
To determine the effect of TPEE on hepatic lipid pro-
files, we estimated total cholesterol (TC), triglycerides
(TG) and free fatty acids (FFA) in all groups of rats.
Table 2 compares and explains lipid profiles of differentTable 1 Effect of TPEE on body and organ weights of
control and HFD-fed rats
Groups Liver Kidney Spleen Testis Body
weight
NC 8.169 ± 1.2 1.693 ± 0.5 0.593 ± 0.2 2.443 ± 0.6 235 ± 3.02
HFD 11.73 ± 1.3# 2.884 ± 0.4# 0.664 ± 0.1 2.83 ± 0.4 460 ± 1.26#
ORL 7.462 ± 1.1* 1.80 ± 0.5* 0.5 ± 0.3 2.698 ± 0.8 340 ± 2.41*
TPEE100 9.919 ± 0.5 2.97 ± 0.3 0.502 ± 0.2 2.803 ± 0.5 425 ± 5.01
TPEE150 8.69 ± 0.5* 2.0 ± 0.3* 0.50 ± 0.2 2.803 ± 0.5 380 ± 1.49*
TPEE200 7.01 ± 0.5* 1.62 ± 0.5* 0.50 ± 1.5 2.71 ± 0.9 350 ± 1.10*
The data are given as mean ± S.D (n = 6). *(P < 0.05). Values are tested by
ANOVA with Duncan’s multiple range tests. #P < 0.05 significantly different
from normal control, *P < 0.05 significantly different from HFD control NC: Normal
control group, HFD: high-fat diet group, ORL: Orlistat, TPEE: T.Paniculata ethanolic
extract (100,150 and 200 mg/kg b.wt/day).groups. TPEE +HFD (100, 150 and 200 mg/kg b.wt) ad-
ministered rats showed reduced TC (12.5%, 26.5% and
39%), TG (15%, 26% and 42%) and FFA (16%, 35% and
56%) levels when compared to HFD fed control group
(Table 2). The above results demonstrated that TPEE at
a dose of 200 mg/kg b.wt showed similar activity as that
of HFD + orlistat treated group.
Activity of liver antioxidant enzymes
To determine the in vivo antioxidant activity, the levels
of superoxide dismutase (SOD), catalase (CAT) and
malondialdehyde (MDA) content were estimated from
the liver tissue. There was a substantial decrease in the
activity of SOD and CAT but raise in MDA content in
HFD-fed groups. However, TPEE (100, 150 and 200 mg/kg
b.wt) administration has significantly reversed these alter-
ations in SOD, CAT and MDA levels. At a dose of 200 mg/
kg b.wt, TPEE increased the activity of SOD and CAT by
62% and 53% respectively but decreased MDA content by
49% as shown in Figure 1.
Effect of TPEE on expression of FAS and AMPK-1α by
RT-PCR
As showed in Figure 2, HFD caused up regulation of fatty
acid synthase (FAS) expression at mRNA level which was
subsequently down regulated by TPEE (100, 150 and
200 mg/kg b.wt) administration (Figures 2A and B). On the
contrary, mRNA expression of AMPK-1α was down regu-
lated by HFD, but, this was up regulated by TPEE adminis-
tration in a dose dependent manner (Figures 3A and B).
Western blot analysis for FAS expression
To further validate our results, we conducted western blot
analysis of FAS, a central enzyme in fatty acid synthesis.
As depicted in Figure 4, FAS expression was up regulated
in HFD-fed rats where as HFD +TPEE (200 mg/kg body
Figure 1 Effect of TPEE on (A) SOD activity (B) CAT activity and (C) MDA content in liver. The data are expressed as the mean ± S.D (n = 6).
Values were tested by ANOVA with Duncan’s multiple range test. *P < 0.05 significantly different from HFD control. NC: Normal control group,
HFD: high-fat diet group, TPEE: T. paniculata ethanolic extract (100,150 and 200 mg/kg b.wt/day).
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of FAS.
Histopathological studies of liver
To evaluate the active role of TPEE on hepatic steatosis
we have examined the Hematoxylan and Eosin stainedFigure 2 Effect of TPEE on expression of FAS mRNA in control and HF
FAS. The values are expressed as mean ± S.D.liver microtome sections. HFD-fed control group rats
showed higher accumulation of lipid droplets, loss of nu-
cleus, inflammatory cells and severe swelling of hepato-
cytes, indicating hepatic steatosis. However, HFD + TPEE
treated groups showed decreased lipid accumulation,
lesser damage and near normal hepatocytes (Figure 5).D-fed rats. (A) Gene expression of FAS. (B) Densitometric values of
Figure 3 Effect of TPEE on expression of AMPK-1α mRNA in control and HFD-fed rats. (A) Gene expression of AMPK-1α. (B) Densitometric
values of AMPK-1α. The values are expressed as mean ± S.D.
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The non alcoholic fatty liver (NAFL) and its progressive
form non alcoholic steatohepatities (NASH) is a com-
mon liver disorder found in dislipidemic and obese con-
ditions. In one end the NAFL, NASH pathological
spectrum of steatosis viewed as without inflammation or
necrosis, but on the other hand its progression appeared
with inflammation, necrosis and liver cirrhosis [16]. In
the present study, significant increase in the weights of
liver and kidney, elevated hepatic total cholesterol, tri-
glycerides and free fatty acids were noticed in addition
to body weight gain in HFD-fed rats. This is in agree-
ment with previous studies on HFD fed rats [5,17]. In
the present study we used three concentrations of TPEE
(100, 150 and 200 mg/kg b.-wt) on HFD-fed rats. We
observed dose dependent activity of these extracts.Figure 4 Effect of TPEE on western blot analyses of FAS in
control and HFD-fed rats.Among the three doses administered 200 mg/kg b.wt of
TPEE was able to significantly (P < 0.05) reduce gain in
body weight, organ weights, as well as TC, TG and FFA.
This suggests a potential role for TPEE in regulation of
fatty acid synthesis, fat accumulation and adipogenesis
by modulating key lipogenic factors such as FAS,
AMPK-1α and other transcriptional regulators [18]. Pre-
vious reports showed that HFD induces oxidative stress,
consequential damage of membrane lipids, proteins and
other macro molecules [18]. It is a known fact that in
enzymatic reactions, SOD converts superoxide anions to
H2O2 (hydrogen peroxide) and the released H2O2 can be
degraded by CAT to H2O [19]. In our study HFD-
induced drop in the activity of SOD and CAT but ele-
vated MDA content was noted in HFD-fed rats. But in
HFD + TPEE (100, 150 and 200 mg/kg b.wt) adminis-
tered rats, raise in SOD and CAT activity but fall in MDA
level was noticed suggesting potent antioxidant property
of TPEE. Elevated SOD and CAT levels in TPEE treated
groups could effectively scavenge the reactive oxygen
species (ROS) and thus minimized lipid peroxidation. In
addition, HFD, devoid of TPEE could cause dysregulated
secretion and release of adipocytokines that might
contribute to steatohepatites and hepatic inflammation
[20,21]. Transcription factors such as PPARs and SREBPs
are involved in regulation of lipid homeostasis by activat-
ing the expression of genes required for the synthesis and
uptake of cholesterol, fatty acids and triglycerides. Particu-
larly, SREBP-1c, one of the pro adipogenic transcription
factors, regulates the expression of FAS and AMPK-1α
which play important role in regulation of lipid and
Figure 5 Effect of TPEE on liver morphology and histopathology in control and HFD-fed rats. NC: Normal control group, HFD: high-fat diet
group, ORL: Orlistat, TPEE: T. paniculata ethanolic extract (100, 150 and 200 mg/kg b.wt/day).
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of glucose [22,23]. To support our results, we have carried
out semiquantitatve reverse transcriptase PCR analysis of
important lipogenic genes such as FAS and AMPK-1α in
hepatic tissue. We have found down regulation of FAS ex-
pression in HFD +TPEE treated groups whose expression
was otherwise increased in HFD-fed group. On the con-
trary, the expression of AMPK-1α was up regulated in
HFD +TPEE treated groups which was otherwise down
regulated in HFD-fed rats. To further confirm the role of
FAS in lipogenesis and fatty liver development, we per-
formed western blot analysis for FAS expression. TPEE
(200 mg/kg b.wt) administration has significantly down
regulated the expression of FAS at protein level in hepatic
tissue. This confirms that FAS expression was controlled
possibly at transcriptional level through PPARs and
SREBPs mediated signaling path way. In fact, our results
on TPEE-mediated down regulation of expression of
PPAR-γ and SREBP-1c also supported this event (data not
shown here). Furthermore, histopathological examination
of liver sections have clearly demonstrated the appearance
of normal hepatocytes with reduced lipid droplets in
HFD + TPEE treated groups. Further studies are needed
to isolate the actual lead molecules from TPEE and to
understand the exact mechanism behind their activity.Conclusions
Based on our biochemical, histopathological and expres-
sion studies, we demonstrate that TPEE potentially at-
tenuates development of non alcoholic fatty liver and
obesity.
Materials and methods
Collection and extraction of plant material
The bark of Terminalia paniculata was collected from
Seshachalam forest spread around Tirupati, Andhra Pra-
desh, India. Its identity was authenticated by a Taxono-
mist, Department of Botany, at S.V. University, Tirupati,
voucher number 136, and a specimen has been pre-
served at the departmental herbarium. The bark of T.
paniculata was dried under shade, pulverized to coarse
powder and extracted with ethanol. The filtrate obtained
was evaporated to dryness at 50-65°C in a rotary vacuum
evaporator to obtain a dark colored molten mass.
Animals
For this study, male Sprague–Dawley rats (n = 36),
weighing 150-160 g were obtained from National Insti-
tute of Nutrition, Hyderabad, India. All rats were housed
under 22 ± 2°C temperature, humidity (40-50%) and
light–dark cycle (12-12 ± 1 h) and allowed food and
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were followed as per Institutional animal ethics commit-
tee guidelines (IAEC) (Regd No: 438/01a/CPCSEA, Date:
17-07-2001). The Committee granted permission to authors
and passed resolution to carryout animal work (Resolution
No: 36/2012-2013/ (i)/a/CPCSEA/IAEC/SVU/MB-MRG).
Composition of high fat diet
High fat diet (HFD) was obtained from National centre
for laboratory animal sciences (NCLAS), National Insti-
tute of Nutrition (NIN), Hyderabad, India. Diet compos-
ition is as follows, Casein (342 g), Cystine (30 g), Starch
(172 g), Sucrose (50 g), Cellulose (50 g), G.N.Oil (25 g),
Thallow (190 g), Mineral mixture (35 g), Vit. Mixture
(10 g).
Experimental design
Rats were randomly divided in to six groups of six each.
Group 1: Normal control group (NC), Group 2: High fat
diet group (HFD), Group 3: HFD+Orlistat (30 mg/kg b.wt),
Group 4: HFD+TPEE (100 mg/kg b.wt), Group 5: HFD+
TPEE (150 mg/kg b.wt) and Group 6: HFD + TPEE
(200 mg/kg b.wt).
Measurement of body and organ weights
At the end of the experimental period, rats were
weighted and their weights noted. Later, they were fasted
overnight, anaesthetized, sacrificed, organs (liver, spleen,
kidney and testis were) were surgically removed, wet
weights were measured with experimental electrical bal-
ance (Shimadzu) and stored at −80°C for further studies.
Estimation of liver lipid profiles
Liver tissues were washed in ice-cold saline (0.9%),
blotted on absorbent paper and weighed. Hepatic lipids
were extracted from 1 g liver with chloroform and
methanol (2:1 v/v) according to the procedure of Folch
[24]. Hepatic cholesterol, triglycerides and free fatty
acids were estimated by commercially available kits
(Randox Laboratories).
Assay of Liver antioxidant enzymes and lipid peroxidation
Superoxide dismutase (SOD) activity was determined
spectrophotometrically according to a modified method
of Beyer and Fridovich [25]. Liver tissue (100 mg) was
lysed in isotonic buffer (10 mM Tric-HCl (pH 7.4), con-
taining 200 mM mannitol, 50 mM sucrose and 1 mM
EDTA) and centrifuged at 8000 rpm for 10 min. The
supernatant was added to a reaction mixture containg
PBS (pH 7.8), 0.1 mM EDTA, 12 mM L-methionine,
75 μM nitroblue tetrazolium (NBT) and 2 μM riboflavin
to a total volume of 3 ml. The reaction mixture was kept
under a fluorescent light for 15 min at 20-25°C and then
measured spectrophotometrically at 240 nm. One unitof SOD represents the amount of enzyme required to in-
hibit the rate of NBT oxidation by 50%. The activity was
expressed as units/mg protein.
Catalase (CAT) activity was measured by a modified
method of Aebi [26]. Hydrogen peroxide (H2O2) decom-
position by CAT was measured spectrophotometrically
at 240 nm. The molar extinction coefficient of
0.043 mM−1 cm−1 was used to determine CAT activity.
One unit of enzyme activity is equal to the micromole of
H2O2 degraded per minute per milligram of protein
(min−1 mg−1).
Lipid peroxidation was estimated by the modified
method of Buege and Aust [27]. Briefly the MDA levels
were estimated by measuring thiobarbituric acid reactive
substances (TBARS) and expressed in terms of malodial-
dehyde (MDA) content. Before the assay, liver tissues
were washed in 0.9% ice-cold saline, blotted on absorb-
ent paper and weighed. Each sample was minced in a
Tri-HCl buffer (pH 7.4) and homogenized. After centri-
fugation at 3000 g for 10 min at 4°C, the clear homogen-
ate was used for biochemical assay. 125 μl of
supernatant (S1) was mixed with 50 μl of PBS (pH7.4),
125 μl of 20% trichloroacetic acid containing 1% butyl-
hydoxytoluene and centrifuged (1000 g, 10 min,4°C).
Then 200 μl of supernatant (S2) was mixed with 40 μl of
HCl (0.6 M) and 160 μl of Tris-Thiobarbituric acid
(120 mM) and the mixture was heated at 80-85°C for 10-
12 min. The absorbance was measured spectrophotometric-
ally at 530 nm. The MDA levels were expressed as μmol/L/
mg protein/mg tissue.
RNA extraction and semiquantitative RT-PCR
Total RNA was isolated from the liver tissue by using
tri-reagent (Sigma-Aldrich, USA) according to manufac-
turer’s protocol and reverse transcribed to obtain cDNA
using DNA synthesis kit (Applied Biosystems, Foster
City, USA). 20 ng of cDNA was used for semi-
quantitative PCR. The PCR amplification was performed
for 38 cycles using the following cycling conditions:
30 sec of denaturation at 94°C, 30 sec of annealing at
59°C and 1 min of extension at 72°C, with following
primers: FAS (F:ATGTGGTACGGAAGGTGGAG; R: T
GGCTACCTTCGTCTGTGTG), AMPK-1α (F: GGTCC
TGGTGGTTTCTGTTG; R: ATGATGTCAGATGGTG
AATT) and RPL-19 (F: CGTCCTCCGCTGTGGTAAA;
R: AGTACCCTTCCTCTTCCCTAT).
Western blot analysis
Liver tissue protein was extracted with lysis buffer
(Sigma Aldrich, USA) and quatified using Bradford
method. Equal amount of proteins were resolved on 10%
SDS-PAGE gel and transferred to nitrocellulose mem-
brane. To block nonspecific binding sites, blots were in-
cubated at 4°C with 5% (v/v) skimmed milk for 1 hr
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of rabbit anti-FAS and mouse anti- β actin (Santa Cruz
Biotechnology, USA) at 1:1000 dilution. The immunore-
active antigen was then recognized by incubation with
Horse radish peroxidase-conjugated secondary antibody
(Santa Cruz Biotechnology). Immunoreactive bands were vi-
sualized with chemiluminescence detection system (Thermo
Fisher Scientific, USA).
Liver morphology and histopathology
Liver tissues from all groups of rats were collected and
kept in 10% formalin solution. A small piece of tissue
was sectioned with microtome, fixed on slides and
stained using haematoxilin and eosin (H&E) staining
procedures and observed under optical microscope.
Statistical analysis
Results are expressed as mean ± S.D (standard devi-
ation). The statistical analysis of results was done by
using t-test and one- way analysis (ANOVA) followed by
Ducan’s. Values with p < 0.05 were considered to be sta-
tistically significant.
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